Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Viruses|December 29, 2017
Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" SettingsBluma G Brenner, Ruxandra-Ilinca Ibanescu, Isabelle Hardy, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutationYudong Quan, Bluma G Brenner, Maureen Oliveira, et al.
The Journal of Infectious Diseases|September 18, 2009
Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variantsYudong Quan, Chen Liang, Bluma G Brenner, et al.
Retrovirology|June 3, 2008
Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case reportYudong Quan, Bluma G Brenner, André Dascal, et al.
Antiviral Therapy|July 21, 2004
The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patientsDan Turner, Jonathan M Schapiro, Bluma G Brenner, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistanceShalom Spira, Mark A Wainberg, Hugues Loemba, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitorsMichel Ntemgwa, Bluma G Brenner, Maureen Oliveira, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2011
Transmission dynamics of the M184V drug resistance mutation in primary HIV infectionMark A Wainberg, Daniela Moisi, Maureen Oliveira, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2023
Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressureBluma G Brenner, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, et al.
AIDS Research and Human Retroviruses|July 3, 2008
Discrepancies in assignment of subtype/recombinant forms by genotyping programs for HIV type 1 drug resistance testing may falsely predict superinfectionMichel Ntemgwa, M John Gill, Bluma G Brenner, et al.
Pageof 7